Home LiteratureArticle Details
PMID: 11349132 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

P2Y(6) nucleotide receptor mediates monocyte interleukin-8 production in response to UDP or lipopolysaccharide.

The Journal of biological chemistry ·Vol. 276 ·No. 28 ·2001-07-13 ·Pages 26051-6

Warny M, Aboudola S, Robson SC, Sévigny J, Communi D, Soltoff SP, Kelly CP

Abstract

Extracellular nucleotides are autocrine and paracrine cellular mediators that signal through P2 nucleotide receptors. Monocytic cells express several P2Y receptors but the role of these G protein-coupled receptors in monocytes is not known. Here, we present evidence that P2Y(6) regulates chemokine production and release in monocytes. We find that UDP, a selective P2Y(6) agonist, stimulates interleukin (IL)-8 release in human THP-1 monocytic cells whereas other nucleotides are relatively inactive. P2 receptor antagonists or P2Y(6) antisense oligonucleotides inhibit IL-8 release induced by UDP. Furthermore, UDP specifically activated IL-8 production in astrocytoma 1321N1 cells transfected with human P2Y(6). Since lipopolysaccharide has been suggested to activate P2 receptors via nucleotide release, we tested whether IL-8 production stimulated by lipopolysaccharide might result from P2Y(6) activation. P2 antagonists or apyrase, an enzyme which hydrolyzes nucleotides including UDP, inhibit IL-8 production induced by lipopolysaccharide but not by other stimuli. Furthermore, IL-8 gene expression activated by lipopolysaccharide is enhanced by P2Y(6) overexpression and inhibited by P2Y(6) antisense oligonucleotides. Thus, UDP activates IL-8 production via P2Y(6) in monocytic cells. Furthermore, lipopolysaccharide mediates IL-8 production at least in part by autocrine P2Y(6) activation. These findings indicate a novel role for P2Y(6) in innate immune defenses.

MeSH Terms
Cell Line Humans Interleukin-8/biosynthesis Lipopolysaccharides/pharmacology Monocytes/metabolism Purinergic P2 Receptor Agonists Receptors, Purinergic P2/metabolism Signal Transduction Uridine Diphosphate/pharmacology
Chemicals
Interleukin-8 Lipopolysaccharides Purinergic P2 Receptor Agonists Receptors, Purinergic P2 purinoceptor P2Y6 Uridine Diphosphate
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Warny M
Gastroenterology Divison, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA. mwarny@caregroup.harvard.edu
Aboudola S
Robson S C
Sévigny J
Communi D
Soltoff S P
Kelly C P
Article Info
Journal
The Journal of biological chemistry
Abbr.
J Biol Chem
ISSN
0021-9258
Published
2001-07-13
Epub
2001-00-10
Pages
26051-6
Language
English
Region
United States
NLM ID
2985121R
Subset
IM
Grants
NIDDK NIH HHS · R01DK54290 · United States
NIDDK NIH HHS · R01DK58858 · United States
NHLBI NIH HHS · R01HL57307 · United States
NHLBI NIH HHS · R01HL63972 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com